Viemed Healthcare, Inc.
VMD
$6.92
$0.324.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 240.88M | 232.79M | 224.26M | 214.30M | 205.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 240.88M | 232.79M | 224.26M | 214.30M | 205.70M |
| Cost of Revenue | 100.37M | 96.11M | 91.05M | 85.13M | 80.33M |
| Gross Profit | 140.52M | 136.68M | 133.20M | 129.18M | 125.37M |
| SG&A Expenses | 119.83M | 116.65M | 112.13M | 107.79M | 104.35M |
| Depreciation & Amortization | 1.39M | 1.42M | 1.48M | 1.57M | 1.65M |
| Other Operating Expenses | -511.00K | -776.00K | -727.00K | -613.00K | -378.00K |
| Total Operating Expenses | 224.28M | 216.51M | 207.01M | 196.79M | 188.70M |
| Operating Income | 16.60M | 16.28M | 17.25M | 17.51M | 17.00M |
| Income Before Tax | 20.43M | 17.71M | 16.17M | 14.94M | 13.68M |
| Income Tax Expenses | 6.14M | 5.20M | 4.76M | 4.48M | 4.21M |
| Earnings from Continuing Operations | 14.29 | 12.52 | 11.41 | 10.46 | 9.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -313.00K | -229.00K | -144.00K | -36.00K | -9.00K |
| Net Income | 13.98M | 12.29M | 11.27M | 10.43M | 9.47M |
| EBIT | 16.60M | 16.28M | 17.25M | 17.51M | 17.00M |
| EBITDA | 42.88M | 41.98M | 42.62M | 42.43M | 41.49M |
| EPS Basic | 0.36 | 0.31 | 0.29 | 0.27 | 0.25 |
| Normalized Basic EPS | 0.25 | 0.23 | 0.25 | 0.25 | 0.25 |
| EPS Diluted | 0.35 | 0.31 | 0.29 | 0.26 | 0.23 |
| Normalized Diluted EPS | 0.24 | 0.21 | 0.23 | 0.24 | 0.24 |
| Average Basic Shares Outstanding | 156.84M | 156.15M | 155.44M | 154.90M | 154.47M |
| Average Diluted Shares Outstanding | 165.01M | 164.48M | 163.44M | 162.30M | 161.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |